Cipla Q4 profit up 73% at ₹412 crore

FILE PHOTO: Employees and security staff work at the reception area of Cipla at its headquarters in Mumbai. (REUTERS)Premium
FILE PHOTO: Employees and security staff work at the reception area of Cipla at its headquarters in Mumbai. (REUTERS)
 1 min read . Updated: 14 May 2021, 07:46 PM IST PTI

NEW DELHI : Drug major Cipla on Friday posted 73 per cent rise in consolidated net profit at ₹412 crore for the fourth quarter ended March 31, 2021 on the back of robust sales across markets.

The Mumbai-based firm had reported a net profit of ₹238 crore in January-March 2019-20.

MORE FROM THIS SECTIONSee All

Total revenue from operations rose to ₹4,606 crore as compared with ₹4,376 crore in the same period of 2019-20, Cipla said in a regulatory filing.

For the entire 2020-21 fiscal year, the drug maker reported a consolidated net profit of ₹2,389 crore as against ₹1,500 crore in the previous year.

Total revenue from operations for the last fiscal year rose to ₹19,160 crore as against ₹17,132 crore in 2019-20.

The company's board recommended a final dividend of ₹5 per share (face value Rs 2 each) for 2020-21.

Cipla shares on Friday ended flat at ₹904.10 apiece on the BSE.

Subscribe to Mint Newsletters
* Enter a valid email
* Thank you for subscribing to our newsletter.

Never miss a story! Stay connected and informed with Mint. Download our App Now!!

Close